Meera Gurumurthy

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis, Tuberculosis Prevention +7

A novel <scp>F₄₂₀</scp>‐dependent anti‐oxidant mechanism protects <i><scp>M</scp>ycobacterium tuberculosis</i> against oxidative stress and bactericidal agents

Meera Gurumurthy, Martin Rao, Tathagata Mukherjee et al. · Molecular Microbiology · 2012 · 124 citations · Full text

Molecular Biology, Bactericidal Agents, Redox Biology +17

Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824

Susan E. Cellitti, Jennifer Shaffer, David H. Jones et al. · Structure · 2012 · 106 citations · Full text

Substrate specificity of the deazaflavin‐dependent nitroreductase from <i>Mycobacterium tuberculosis</i> responsible for the bioreductive activation of bicyclic nitroimidazoles

Meera Gurumurthy, Tathagata Mukherjee, Cynthia S. Dowd et al. · FEBS Journal · 2011 · 86 citations · Full text

Combinatorial Chemistry, Bioorganic Chemistry, Nitric Oxide +20

Nucleophosmin Interacts with HEXIM1 and Regulates RNA Polymerase II Transcription

Meera Gurumurthy, Chuan Hao Tan, Raymond W. M. Ng et al. · Journal of Molecular Biology · 2008 · 53 citations

Transcriptional Regulation, Systems Biology, Engineering +7